PMID: 702059Oct 1, 1978Paper

Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator

The Journal of Experimental Medicine
Teizo FujitaV Nussenzweig

Abstract

We recently described the isolation from human serum of a high molecular weight protein with specific binding affinity for fluid-phase activated C4. We show here that the C4-binding protein (C4-Bp) functions as an essential cofactor in the proteolysis of C4b in the presence of C3b-inactivator (C3bINA). C4-bp, together with C3bINA, cleave the alpha'-chain of C4b into three fragments called alpha2, alpha3, and alpha4, with mol wt of 47,000, 25,000, and 17,000 daltons, respectively. The alpha2 fragment was dissociated from C4b without reduction, whereas the alpha3 and alpha4 fragments were disulfide bonded the other chains of C4b. The reaction did not occur when either C4-bp or C3bINA were omitted, nor in the presence of either protein in combination with beta1H. Native C4 was not affected by C3bINA aand C4-bp. C4b was not cleaved when incubated in serum of a patient with genetic deficiency of C3bINA. However, when purified C3bINA was added, the alpha'-chain of C4b was cleaved and fragments with the same molecular weight as alpha2, alpha3, and alpha4 were generated.

References

Apr 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·D T Fearon, K F Austen
Jul 1, 1978·The Journal of Experimental Medicine·J ScharfsteinV Nussenzweig
Dec 1, 1975·Immunochemistry·S Shiraishi, R M Stroud
Sep 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·J M WeilerD T Fearon

❮ Previous
Next ❯

Citations

Jan 1, 1985·Human Genetics·S Nakamura, K Abe
Jan 1, 1985·Immunogenetics·S Rodríguez de CórdobaP Rubinstein
Jan 1, 1994·Springer Seminars in Immunopathology·K R KalliD T Fearon
Jan 1, 1984·Springer Seminars in Immunopathology·M K Pangburn, H J Müller-Eberhard
Jan 1, 1991·Immunologic Research·S R Barnum
Jun 8, 2010·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·David Kavanagh, Tim Goodship
Nov 30, 1987·Clinica Chimica Acta; International Journal of Clinical Chemistry·D K Strickland, C M Kessler
Dec 1, 1982·Molecular Immunology·A LundwallJ Sjöquist
May 23, 2001·International Immunopharmacology·S RamP A Rice
Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·I GigliV Nussenzweig
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·B Dahlbäck, J Stenflo
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·T KaidohM Takahashi
Jan 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A C ChanJ P Atkinson
Jun 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·B DahlbäckH J Müller-Eberhard
Aug 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·A Nicholson-WellerK F Austen
Dec 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·S Rodriguez de CordobaP Rubinstein
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·T Kristensen, B F Tack
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G L HortinJ P Atkinson
Jun 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·F Pardo-ManuelS Rodriguez de Cordoba
Feb 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A Hillarp, B Dahlbäck
Aug 1, 1979·The Journal of Experimental Medicine·T Fujita, V Nussenzweig
May 1, 1981·The Journal of Experimental Medicine·K Iida, V Nussenzweig
Jul 1, 1981·The Journal of Experimental Medicine·I GigliJ Leibowitch
Oct 1, 1981·The Journal of Experimental Medicine·F C de BeerM B Pepys
Sep 1, 1988·The Journal of Experimental Medicine·C MoldN R Cooper
May 1, 1991·The Journal of Experimental Medicine·S Rodriguez de CordobaJ Rey-Campos
Nov 1, 1993·Annals of the Rheumatic Diseases·Y SatoT Fujita
Aug 1, 1980·Journal of Clinical Pathology·J T WhicherS Radford

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.